vs
Assertio Holdings, Inc.（ASRT）与FVCBankcorp, Inc.（FVCB）财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是Assertio Holdings, Inc.的1.2倍（$16.9M vs $13.5M），FVCBankcorp, Inc.同比增速更快（4377.5% vs -57.9%），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
ASRT vs FVCB — 直观对比
营收规模更大
FVCB
是对方的1.2倍
$13.5M
营收增速更快
FVCB
高出4435.4%
-57.9%
两年增速更快
FVCB
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $16.9M |
| 净利润 | — | — |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 43.7% |
| 净利率 | — | — |
| 营收同比 | -57.9% | 4377.5% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-4.54 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFVCB
| Q4 25 | $13.5M | $16.9M | ||
| Q3 25 | $49.5M | $416.0K | ||
| Q2 25 | $29.2M | $15.8M | ||
| Q1 25 | $26.5M | $382.0K | ||
| Q4 24 | $32.2M | $378.0K | ||
| Q3 24 | $29.2M | $412.0K | ||
| Q2 24 | $31.1M | $415.0K | ||
| Q1 24 | $32.4M | $359.0K |
净利润ASRTFVCB
| Q4 25 | — | — | ||
| Q3 25 | $11.4M | $5.6M | ||
| Q2 25 | $-16.4M | $5.7M | ||
| Q1 25 | $-13.5M | $5.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.9M | $4.7M | ||
| Q2 24 | $-3.7M | $4.2M | ||
| Q1 24 | $-4.5M | $1.3M |
营业利润率ASRTFVCB
| Q4 25 | -86.7% | 43.7% | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | -27.5% | 45.9% | ||
| Q1 25 | -50.0% | — | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -11.6% | — | ||
| Q1 24 | -13.4% | — |
净利率ASRTFVCB
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | 1341.1% | ||
| Q2 25 | -56.0% | 36.0% | ||
| Q1 25 | -51.1% | 1352.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.0% | 1133.3% | ||
| Q2 24 | -11.8% | 1001.2% | ||
| Q1 24 | -13.9% | 373.3% |
每股收益（稀释后）ASRTFVCB
| Q4 25 | $-4.54 | $0.31 | ||
| Q3 25 | $0.11 | $0.31 | ||
| Q2 25 | $-0.17 | $0.31 | ||
| Q1 25 | $-0.14 | $0.28 | ||
| Q4 24 | $-3.28 | $0.27 | ||
| Q3 24 | $-0.03 | $0.25 | ||
| Q2 24 | $-0.04 | $0.23 | ||
| Q1 24 | $-0.05 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $253.6M |
| 总资产 | $267.0M | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTFVCB
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTFVCB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTFVCB
| Q4 25 | $94.0M | $253.6M | ||
| Q3 25 | $105.8M | $249.8M | ||
| Q2 25 | $93.3M | $243.2M | ||
| Q1 25 | $108.5M | $242.3M | ||
| Q4 24 | $121.1M | $235.4M | ||
| Q3 24 | $130.5M | $230.8M | ||
| Q2 24 | $132.2M | $226.5M | ||
| Q1 24 | $134.5M | $220.7M |
总资产ASRTFVCB
| Q4 25 | $267.0M | $2.3B | ||
| Q3 25 | $319.8M | $2.3B | ||
| Q2 25 | $273.8M | $2.2B | ||
| Q1 25 | $286.4M | $2.2B | ||
| Q4 24 | $284.7M | $2.2B | ||
| Q3 24 | $276.0M | $2.3B | ||
| Q2 24 | $279.4M | $2.3B | ||
| Q1 24 | $282.0M | $2.2B |
负债/权益比ASRTFVCB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $23.9M |
| 自由现金流经营现金流 - 资本支出 | — | $23.8M |
| 自由现金流率自由现金流/营收 | — | 140.7% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $40.0M |
8季度趋势，按日历期对齐
经营现金流ASRTFVCB
| Q4 25 | $-30.0M | $23.9M | ||
| Q3 25 | $-4.8M | $7.6M | ||
| Q2 25 | $19.1M | $3.3M | ||
| Q1 25 | $-12.5M | $5.4M | ||
| Q4 24 | $11.5M | $18.2M | ||
| Q3 24 | $-35.0K | $4.7M | ||
| Q2 24 | $7.4M | $1.6M | ||
| Q1 24 | $7.5M | $7.2M |
自由现金流ASRTFVCB
| Q4 25 | — | $23.8M | ||
| Q3 25 | — | $7.6M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $7.1M |
自由现金流率ASRTFVCB
| Q4 25 | — | 140.7% | ||
| Q3 25 | — | 1818.0% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | — | 1413.6% | ||
| Q4 24 | — | 4786.0% | ||
| Q3 24 | — | 1121.8% | ||
| Q2 24 | — | 361.2% | ||
| Q1 24 | — | 1988.3% |
资本支出强度ASRTFVCB
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | 0.0% | 14.1% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 3.9% |
现金转化率ASRTFVCB
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FVCB
暂无分部数据
